MX2010003511A - Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano. - Google Patents
Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano.Info
- Publication number
- MX2010003511A MX2010003511A MX2010003511A MX2010003511A MX2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A MX 2010003511 A MX2010003511 A MX 2010003511A
- Authority
- MX
- Mexico
- Prior art keywords
- cells
- umbilical cord
- preservation
- isolation
- precursor cells
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Materials For Medical Uses (AREA)
- Cosmetics (AREA)
Abstract
La presente invención se refiere a un método optimizado y definido para el aislamiento y conservación de células precursoras a partir del cordón umbilical humano. Además de ser reproducible y 100% confiable en términos del número de muestras procesadas, el método resulta en un número alto y definido de células precursoras, la mayoría que se obtienen después de una fase de adhesión sencilla y de expansión/multiplicación ex vivo (otorgando así un fenotipo celular), en un marco de tiempo más corto que aquel que fue previamente descrito en el estado del arte. Con este método, es posible obtener en 9 días, después de congelamiento directo de una fracción celular, y después de una fase de expansión/multiplicación ex vivo (final de PO) de la mayoría de las células, alrededor de 8.6 (±0.1) x 105 células/gramo de cordón umbilical procesado. A su vez, las características de las células permiten por ejemplo, después de 35 días, obtener un promedio de 7.7 x 1015 células, con fenotipo del precursor, a partir del 100% de las muestras procesadas de cordón umbilical. El método, debido a que es sencillo, sólido y 100% confiable, se puede efectuar bajo buenas prácticas de manufactura (GMP) en laboratorios dedicados a la terapia celular en humanos. Además, el método tiene aplicaciones las áreas farmacéutica, de cosmética y biotecnología.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT103843A PT103843B (pt) | 2007-10-04 | 2007-10-04 | Método de isolamento de células precursoras a partir do cordão umbilical humano |
| PCT/IB2008/054067 WO2009044379A2 (en) | 2007-10-04 | 2008-10-03 | Optimised and defined method for isolation and preservation of precursor cells from human umbilical cord |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010003511A true MX2010003511A (es) | 2010-09-10 |
Family
ID=40456372
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010003511A MX2010003511A (es) | 2007-10-04 | 2008-10-03 | Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano. |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9546353B2 (es) |
| EP (1) | EP2203555B1 (es) |
| JP (1) | JP5785394B2 (es) |
| KR (1) | KR20100087705A (es) |
| CN (1) | CN101868536B (es) |
| AU (1) | AU2008306442B2 (es) |
| BR (1) | BRPI0817522A2 (es) |
| CA (1) | CA2701907A1 (es) |
| EA (1) | EA025532B1 (es) |
| ES (1) | ES2582369T3 (es) |
| IL (1) | IL204788A (es) |
| MX (1) | MX2010003511A (es) |
| PT (1) | PT103843B (es) |
| WO (1) | WO2009044379A2 (es) |
| ZA (1) | ZA201002260B (es) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2576768B1 (en) | 2010-06-01 | 2017-05-10 | Auxocell Laboratories, Inc. | Native wharton's jelly stem cells and their purification |
| CN104204190B (zh) * | 2010-10-18 | 2017-02-01 | 尚翔股份有限公司 | 人类多能性类胚胎干细胞先驱细胞 |
| TWI535377B (zh) * | 2011-09-01 | 2016-06-01 | Storage, culture and application of umbilical cord tissue and its derived cells | |
| EP3321355B1 (en) | 2011-12-30 | 2021-08-25 | Amit Patel | Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses |
| CN102550543B (zh) * | 2012-02-10 | 2014-04-16 | 四川新生命干细胞科技股份有限公司 | 用于保存脐带组织的液体 |
| CN103461322B (zh) * | 2012-06-07 | 2016-08-03 | 西比曼生物科技（上海）有限公司 | 用于冻存复苏后的细胞的保存液 |
| EP2756754B1 (de) | 2013-01-17 | 2017-01-04 | Vita 34 Ag | Verfahren zur Behandlung von Nabelschnurgewebe, insbesondere im Zusammenhang mit der Konservierung des Gewebes |
| EP3149157A4 (en) * | 2014-05-24 | 2018-06-13 | Neelamkrishnan Venkataramanaa | A method for targettingglioblastoma with wharton jelly-mesenchymal stem cells (wj-msc) derived from human umbilical cord |
| EP3215224A4 (en) * | 2014-11-05 | 2018-06-27 | Tissuetech, Inc. | Compositions and method for promoting nerve growth and regeneration |
| WO2017004460A1 (en) * | 2015-06-30 | 2017-01-05 | Surgenex, LLC | Compositions and methods for flowable allograft tissue |
| EP3388512B1 (en) * | 2015-12-11 | 2023-08-23 | Lei Guo | Method for separating and culturing mesenchymal stem cells from wharton's jelly tissue of umbilical cord |
| WO2019175773A1 (en) | 2018-03-12 | 2019-09-19 | Universidade Do Porto | Compositions for use in the treatment of musculoskeletal conditions and methods for producing the same leveraging the synergistic activity of two different types of mesenchymal stromal/stem cells |
| CN112342191A (zh) * | 2019-08-07 | 2021-02-09 | 路春光 | hMSC生产试剂盒开发和质量管理标准优化和体系建立 |
| CN111893092A (zh) * | 2020-06-28 | 2020-11-06 | 国大生命科学产业集团(深圳)有限公司 | 一种人脐带来源的间充质干细胞及其制备方法 |
| CN113025567A (zh) * | 2021-03-31 | 2021-06-25 | 中国人民解放军陆军特色医学中心 | 一种椎间盘单细胞的分离方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT402890B (de) * | 1994-03-16 | 1997-09-25 | Berbi Gmbh | Verwendung von notoginsenosid r1 zur herstellung von arzneimitteln |
| AU2003221173A1 (en) * | 2002-03-27 | 2003-10-08 | Asahi Kasei Kabushiki Kaisha | Placenta-origin mesenchymal cells and medicinal use thereof |
| US9598669B2 (en) * | 2005-12-29 | 2017-03-21 | Anthrogenesis Corporation | Composition for collecting placental stem cells and methods of using the composition |
| US9102915B2 (en) * | 2006-11-13 | 2015-08-11 | DePuy Synthes Products, Inc. | In vitro expansion of postpartum-derived cells using microcarriers |
-
2007
- 2007-10-04 PT PT103843A patent/PT103843B/pt active IP Right Grant
-
2008
- 2008-10-03 KR KR1020107009850A patent/KR20100087705A/ko not_active Application Discontinuation
- 2008-10-03 CN CN200880114557.0A patent/CN101868536B/zh not_active Expired - Fee Related
- 2008-10-03 MX MX2010003511A patent/MX2010003511A/es active IP Right Grant
- 2008-10-03 EP EP08807881.1A patent/EP2203555B1/en not_active Not-in-force
- 2008-10-03 CA CA2701907A patent/CA2701907A1/en not_active Abandoned
- 2008-10-03 WO PCT/IB2008/054067 patent/WO2009044379A2/en active Application Filing
- 2008-10-03 EA EA201000425A patent/EA025532B1/ru not_active IP Right Cessation
- 2008-10-03 US US12/680,604 patent/US9546353B2/en active Active
- 2008-10-03 ES ES08807881.1T patent/ES2582369T3/es active Active
- 2008-10-03 BR BRPI0817522-5A2A patent/BRPI0817522A2/pt not_active Application Discontinuation
- 2008-10-03 AU AU2008306442A patent/AU2008306442B2/en not_active Ceased
- 2008-10-03 JP JP2010527592A patent/JP5785394B2/ja not_active Expired - Fee Related
-
2010
- 2010-03-28 IL IL204788A patent/IL204788A/en not_active IP Right Cessation
- 2010-03-30 ZA ZA2010/02260A patent/ZA201002260B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP5785394B2 (ja) | 2015-09-30 |
| WO2009044379A3 (en) | 2009-05-22 |
| WO2009044379A2 (en) | 2009-04-09 |
| CN101868536B (zh) | 2015-03-25 |
| IL204788A (en) | 2013-07-31 |
| CA2701907A1 (en) | 2009-04-09 |
| US9546353B2 (en) | 2017-01-17 |
| IL204788A0 (en) | 2010-12-30 |
| EP2203555B1 (en) | 2016-04-13 |
| CN101868536A (zh) | 2010-10-20 |
| AU2008306442B2 (en) | 2014-12-04 |
| EP2203555A2 (en) | 2010-07-07 |
| PT103843B (pt) | 2008-08-12 |
| BRPI0817522A2 (pt) | 2014-10-14 |
| ZA201002260B (en) | 2011-06-29 |
| US20100216237A1 (en) | 2010-08-26 |
| EA201000425A1 (ru) | 2010-10-29 |
| ES2582369T3 (es) | 2016-09-12 |
| PT103843A (pt) | 2008-01-09 |
| EA025532B1 (ru) | 2017-01-30 |
| KR20100087705A (ko) | 2010-08-05 |
| AU2008306442A1 (en) | 2009-04-09 |
| JP2010539970A (ja) | 2010-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2010003511A (es) | Método optimizado y definido para el aislamiento y conservación de células precursoras del cordón umbilical humano. | |
| Ha et al. | Mesenchymal stem/stromal cell-derived exosomes for immunomodulatory therapeutics and skin regeneration | |
| Neri et al. | Molecular mechanisms contributing to mesenchymal stromal cell aging | |
| EP3190180A3 (en) | A method for identifying, expanding, and removing adult stem cells and cancer stem cells | |
| WO2019232504A3 (en) | Method and apparatus for processing tissue samples | |
| MXPA02006145A (es) | Metodo para el aislamiento de arn de especimenes de tejido incluido en parafina fijo en formalina. | |
| WO2016070166A3 (en) | Messenger una molecules and uses thereof | |
| WO2012048093A3 (en) | Enhanced msc preparations | |
| WO2007099534A3 (en) | Compostions and populations of cells obtained from the umbilical cord and methods of producing the same | |
| EP3275901A8 (en) | Human embryonic stem cell methods and podxl expression | |
| WO2009003493A3 (en) | Mhc multimers, methods for their generation, labeling and use | |
| WO2009075774A3 (en) | Glycosaminoglycan-coated particles and uses thereof | |
| JP2007191482A (ja) | ストレスにさらされている生細胞とさらされていない生細胞とを用いた少なくとも１つの生物学的パラメーターに結果的に生じた変化の同定法 | |
| WO2005044367A3 (en) | Method and apparatus for cell permeabilization | |
| WO2009099685A3 (en) | High pressure enzymatic digestion system for protein characterization | |
| Khan et al. | Exosomes: emerging diagnostic and therapeutic targets in cutaneous diseases | |
| WO2006084299A8 (en) | Method for evaluating the allergen sensitivity of an individual | |
| WO2003016464A3 (en) | Cancer specific oligosaccharide sequences and use thereof | |
| WO2006039396A3 (en) | Non-embedded tissue microarray technology for protein and nucleic acid analyses | |
| WO2015103645A3 (en) | Srm assay for pd-l1 | |
| DE69935999D1 (de) | Methoden zur introduktion heterologer zellen in fische | |
| WO2010032008A3 (en) | Dendritic cell modulatory molecule | |
| FI3642331T3 (fi) | T-solujen monistusmenetelmä ja käyttöjä | |
| WO2009035612A3 (en) | Multilineage-inducible cells and uses thereof | |
| Sari et al. | Omics technologies for high-throughput-screening of cell–biomaterial interactions |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HH | Correction or change in general | ||
| FG | Grant or registration |